indomethacin has been researched along with Ankylosis in 4 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Ankylosis: Fixation and immobility of a joint.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indomethacin was administered for 6 weeks beginning at weaning to litters from heterozygote breeder pairs." | 5.28 | Transient inhibition of murine progressive ankylosis by indomethacin. ( Krug, HE; Mahowald, ML, 1991) |
| "Thirty-nine patients (46 elbows) with heterotopic ossification treated with excision were identified: 10 patients (16 elbows) had burns, 28 patients (29 elbows) had trauma, and one patient (one elbow) had a closed head injury." | 1.40 | Heterotopic ossification of the elbow treated with surgical resection: risk factors, bony ankylosis, and complications. ( Golz, A; Israel, H; Marra, G; Salazar, D, 2014) |
| "Heterotopic ossification is a frequent complication after spinal cord injury." | 1.39 | Ankylosing pelvitrochanteric heterotopic ossification in a patient with spinal cord injury. ( Gurcan, S; Kose, O; Ozyurek, S; Sehirlioglu, A, 2013) |
| "In an attempt to prevent postoperative recurrence of ossification, 100 mg of indomethacin was administered daily after surgery for 6 weeks." | 1.30 | Operative treatment of heterotopic hip ossification in patients with coma after brain injury. ( Caterini, R; Farsetti, P; Formisano, R; Ippolito, E; Penta, F, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurcan, S | 1 |
| Ozyurek, S | 1 |
| Kose, O | 1 |
| Sehirlioglu, A | 1 |
| Salazar, D | 1 |
| Golz, A | 1 |
| Israel, H | 1 |
| Marra, G | 1 |
| Ippolito, E | 1 |
| Formisano, R | 1 |
| Caterini, R | 1 |
| Farsetti, P | 1 |
| Penta, F | 1 |
| Krug, HE | 1 |
| Mahowald, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Elbow Heterotopic Ossifications Associated With Radial Head Prosthesis: Risk and Prognostic Factors[NCT05547867] | 60 participants (Anticipated) | Observational | 2022-09-12 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for indomethacin and Ankylosis
| Article | Year |
|---|---|
Ankylosing pelvitrochanteric heterotopic ossification in a patient with spinal cord injury.
Topics: Adult; Ankylosis; Anti-Inflammatory Agents, Non-Steroidal; Female; Hip Joint; Humans; Indomethacin; | 2013 |
Heterotopic ossification of the elbow treated with surgical resection: risk factors, bony ankylosis, and complications.
Topics: Adolescent; Adult; Aged; Ankylosis; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena | 2014 |
Operative treatment of heterotopic hip ossification in patients with coma after brain injury.
Topics: Adolescent; Adult; Ankylosis; Anti-Inflammatory Agents, Non-Steroidal; Brain Injuries; Coma; Female; | 1999 |
Transient inhibition of murine progressive ankylosis by indomethacin.
Topics: Animals; Ankylosis; Bone and Bones; Female; Indomethacin; Male; Mice; Mice, Inbred Strains | 1991 |